Savara's Grant - II Round

Savara raised a round of funding on May 16, 2011. Investors include Qualifying Therapeutic Discovery Project.

Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare res…

Articles about Savara's Grant - II Round: